AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Paul Rowe
Public Documents
1
December 20, 2022
Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardl...
Ian Pavord, Arnaud Bourdin, Alberto Papi, et al.
